Literature DB >> 24595558

History of Kawasaki disease.

Tomisaku Kawasaki1, Shiro Naoe.   

Abstract

We describe a short history of Kawasaki disease. In 1967, we published a paper entitled 'Infantile acute febrile mucocutaneous lymph node syndrome with specific desquamation of the fingers and toes. Clinical observation of 50 cases'; this was the first report on what is now called Kawasaki disease. Since then, many reports on cardiology, treatment, epidemiology, pathology and etiology of Kawasaki disease have been published. Furthermore, a recent Chapel Hill Consensus Statement on Kawasaki disease in the classification of vasculitis is given, along with a figure on the relationship and classification of childhood vasculitis by autopsy material.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595558     DOI: 10.1007/s10157-013-0877-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  6 in total

1.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

2.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

3.  Infliximab treatment for refractory Kawasaki syndrome.

Authors:  Jane C Burns; Wilbert H Mason; Sarmistha B Hauger; Hillel Janai; John F Bastian; Julie D Wohrley; Ian Balfour; Cynthia A Shen; Edward D Michel; Stanford T Shulman; Marian E Melish
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

4.  Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease.

Authors:  H Nakano; K Ueda; A Saito; K Nojima
Journal:  Am J Cardiol       Date:  1985-11-15       Impact factor: 2.778

5.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

6.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

  6 in total
  10 in total

1.  Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Authors:  Seigo Okada; Hiroki Yasudo; Yuji Ohnishi; Chie Matsuguma; Reiji Fukano; Takahiro Motonaga; Takako Waniishi; Shunji Hasegawa
Journal:  Inflammation       Date:  2022-10-08       Impact factor: 4.657

2.  Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease.

Authors:  Elaheh Malakan Rad; Iran Malekzadeh; Vahid Ziaee; Raheleh Rajabi; Zohreh Shahabi
Journal:  Iran J Pediatr       Date:  2016-08-01       Impact factor: 0.364

3.  Atypical desquamation in a 2.5-year-old boy with Kawasaki disease: A case report.

Authors:  Ali Adib; Ali Fazel; Seyed Hesamedin Nabavizadeh; Sohaila Alyasin; Sara Kashef
Journal:  Electron Physician       Date:  2017-02-25

4.  Coronary Artery Dilation in Children with Febrile Exanthematous Illness without Criteria for Kawasaki Disease -An Enigmatic Disease.

Authors:  Vitor Coimbra Guerra
Journal:  Arq Bras Cardiol       Date:  2019-12       Impact factor: 2.000

5.  Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease.

Authors:  Yunfei Liao; Ben Ke; Xiaoyan Long; Jianjun Xu; Yongbing Wu
Journal:  Biomed Res Int       Date:  2022-07-25       Impact factor: 3.246

6.  Blackfly fever and dermatitis caused by Simulium kiritshenkoi: a human case report in Iran.

Authors:  Farbod Tabatabaei; Sahar Azarmi; Mohammad Javad Abbaszadeh Afshar; Hamed Yarizadeh; Sina Mohtasebi
Journal:  BMC Infect Dis       Date:  2020-05-15       Impact factor: 3.090

7.  Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum.

Authors:  Noriko Iwamoto; Kotoko Yokoyama; Megumi Takanashi; Atsushi Yonezawa; Kazuo Matsubara; Takashi Shimada
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

8.  Electrocardiographic Analysis of Repolarization Changes in South Indian Children with Kawasaki Disease after the Acute Phase of Illness.

Authors:  Siddhartha Reddy; Maneesh Rai; Ravi Raj Singh Chouhan; Suchetha Rao; Nutan Kamath
Journal:  Int J Pediatr       Date:  2018-07-02

9.  Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease.

Authors:  Yu-Ran Lee; Eun Young Bae; Hong Ryang Kil; Byeong-Hwa Jeon; Geena Kim
Journal:  Biomedicines       Date:  2022-01-17

10.  Adult onset Kawasaki disease presenting with acute epiglottitis findings.

Authors:  Daichi Murakami; Gen Sugita; Mehmet Gunduz; Tomohiro Suenaga; Takashi Takeuchi; Hiroyuki Suzuki; Muneki Hotomi
Journal:  Braz J Otorhinolaryngol       Date:  2017-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.